Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 71.28M P/E - EPS this Y 65.00% Ern Qtrly Grth -
Income -156.09M Forward P/E -0.72 EPS next Y -17.50% 50D Avg Chg -5.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -47.00%
Dividend N/A Price/Book 0.23 EPS next 5Y - 52W High Chg -93.00%
Recommedations 2.00 Quick Ratio 14.34 Shares Outstanding 6.50M 52W Low Chg 16.00%
Insider Own 6.84% ROA -14.01% Shares Float 3.06M Beta 1.18
Inst Own 66.25% ROE -52.96% Shares Shorted/Prior 7.45K/8.75K Price 0.55
Gross Margin - Profit Margin - Avg. Volume 610,745 Target Price 20.33
Oper. Margin - Earnings Date Aug 12 Volume 236,569 Change -0.36%
About Instil Bio, Inc.

Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

TIL Chatroom

User Image goingup71 Posted - 2 days ago

$NSAV $TSLA $TIL $FCEL Number 1 searched by far. This is crazy. Q1 revenue blowout!!!

User Image Flowdollas Posted - 1 week ago

$NVAX Bears!. Let it go with the scare tactics. WE'RE NOT SELLING. Need at least $100 per share for pain, manipulation and suffering. We got manhandled by Big P. We've been on the ropes 2 years using the old Ali rope a dope defense. Poor shorty keeps swinging and Nova OGs hands down are the most patient, loyal, smart and resilient retail shareholders on Wallstreet. Long & Strong and it aint just about covid y'all. Do your own DD! FOMO time!👑💎🥊 $Til $TSLA $MSFT

User Image DonCorleone77 Posted - 1 week ago

$TIL Instil Bio sees cash runway beyond 2026 As of March 31, 2024, Instil had cash, cash equivalents, marketable securities and long-term investments of $161.5 million, which consisted of $5.5 million in cash and cash equivalents, $148.3 million in marketable securities and $7.7 million in long-term investments, compared to $175.0 million in total cash, cash equivalents, restricted cash, marketable securities and long-term investments, which consisted of $9.2 million in cash and cash equivalents, $1.5 million in restricted cash, $141.2 million marketable securities and $23.2 million in long-term investments as of December 31, 2023. Instil expects that its cash, cash equivalents, marketable securities and long-term investments as of March 31, 2024 will enable it to fund its current operating plan beyond 2026.

User Image DonCorleone77 Posted - 1 week ago

$TIL Instil Bio reports Q1 adjusted EPS ($2.39) vs. ($4.29) last year Research and development expenses were $7.3 million for the three months ended March 31, 2024, compared to $20.7 million for the three months ended March 31, 2023. General and administrative expenses were $12.4 million for the three months ended March 31, 2024, compared to $13.2 million for the three months ended March 31, 2023.

User Image Stock_Titan Posted - 1 week ago

$TIL Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update https://www.stocktitan.net/news/TIL/instil-bio-reports-first-quarter-2024-financial-results-and-provides-q5k13y2xjqhx.html

User Image Magic8BallResponse Posted - 04/25/24

$TIL Cable Car with the share add.....

User Image Magic8BallResponse Posted - 04/23/24

$TIL Sell facility. Distribute cash. Call it a day.

User Image Magic8BallResponse Posted - 1 month ago

$TIL Cash value plus option on facility.... bingo

User Image Bakhmutbull2 Posted - 1 month ago

$TIL Starting to look like its time to start a new position. There is going to be a merger of some sort in my view, that may or may not be good.

User Image Magic8BallResponse Posted - 03/28/24

$TIL WuXi for the win!

User Image Magic8BallResponse Posted - 03/22/24

$TIL Plenty of cash here. Banking on facility proceeds as well. s/b $20

User Image Stock_Titan Posted - 03/21/24

$TIL Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update https://www.stocktitan.net/news/TIL/instil-bio-reports-fourth-quarter-and-full-year-2023-financial-nfomfe2ejjjc.html

User Image Magic8BallResponse Posted - 2 months ago

$TIL Facility sale likely got a boost with the $IOVA approval. Plug and play

User Image kiwitc2000 Posted - 2 months ago

$TIL A biotech flush with cash, microscopic float and trading in a very tight range above the magic five dollar mark. Do you see what I see?

User Image TickerDD_com Posted - 02/26/24

From 2/13/2024, looking back across 22 Month-Ends for TIL, Percentage Change of Average Monthly Price had More Negatives (77%) while Percentage Change of Average Monthly Volume had All Positives (100%) $TIL #TIL #TILStock #TickerDD #TILPrice https://www.youtube.com/watch?v=jeEVq0m7L60

User Image filizius Posted - 02/24/24

$TIL news+data q1 ahead

User Image Magic8BallResponse Posted - 02/22/24

$IOVA $LYEL $TIL $TSBX let's Go!

User Image Magic8BallResponse Posted - 3 months ago

$TIL Looks like IOVA with the the win. Have to imagine they raise $ and pick up ObsidianTX along the way

User Image JrChase Posted - 3 months ago

$TIL Target Projection $600🎯

User Image filizius Posted - 3 months ago

$TIL

User Image Magic8BallResponse Posted - 3 months ago

$TIL Speculators looking for cash might grow impatient. Fully expect this facility to sell as it is state of the art. For a special and well funded bio this would be magical.

User Image Magic8BallResponse Posted - 3 months ago

$TIL https://www.costar.com/article/87911713/silicon-valley-biotech-company-axes-deal-for-alexandria-owned-hq Oh the fun being a landlord these days....

User Image Bakhmutbull2 Posted - 01/26/24

$TIL They unofficially have the for sale or merger sign out. This is a make or break moment. Do they do the right thing for shareholders and distribute cash or merge with a legit bio or AI company or do they do a RM with Hobo pharma.

User Image EarningsInsider Posted - 01/26/24

Instil Bio Sees Short Interest Decrease from 15,400 shares to 9,800 shares. $TIL https://www.marketbeat.com/stocks/NASDAQ/TIL/short-interes

User Image ChartMill Posted - 01/24/24

$TIL is being bought by large players and show a pocket pivot signal today. https://www.chartmill.com/stock/stock-screener?sid=31&f=smlev20v_b_lev,smlev20v_r,p_pg10,pp_1,v1_50b200,cu_a_sm50v,der5_a_0.03,s_ppt,exch_us&v=3&timeframe=DAILY&type=CANDLES&o1=17&op1=10%252C2,16711680&i1=49&ia1=on&cl=F&months=0.05&o2=3&op2=50,255&width=720&o3=3&op3=10,65280&utm_source=large_effective_volume_+_pocket_pivot_today&utm_medium=stocktwits&utm_campaign=screen

User Image TrendyChart Posted - 01/23/24

$TIL Support levels act as the bedrock, preventing the stock chart from succumbing to market turbulence and ensuring its enduring stability. 📈 https://thetrendychart.com/

User Image StockAutomatePro Posted - 01/23/24

$TIL Chart is suggesting a bright future for the stock price. We alerted the BUY signal at $7.61 and we were able to close this one with profit at $10.93 ✅

User Image VirginiaPak Posted - 01/23/24

$TIL I’ve made $147,883.65 with their alerts, Big thanks to this chat room. Make as much as you want,,..--'👉 top-stocks-great-winning-trades-chat.profitablestocks.vip/

User Image Louis_Profitlabfx Posted - 01/22/24

$TIL $DJT Our analyst's entry call on $KITT led to a 50% profit increase for our FREE trial members! $ATGL $CZOO Trial Link in Profile 👉 @Louis_Profitlabfx

User Image Thestocktraderhubzee Posted - 01/22/24

WATCHLIST JAN 22 2024.. $ATGE Barrington Research Maintains Outperform on Adtalem Glb Education, Raises Price Target to $65 $FUL Baird Reiterates Neutral on H.B. Fuller, Maintains $80 Price Target $TIL Baird Reiterates Outperform on Instil Bio, Maintains $54 Price Target $BANF DA Davidson Maintains Neutral on BancFirst, Lowers Price Target to $92 $QCOM Canaccord Genuity Maintains Buy on Qualcomm, Raises Price Target to $175

Analyst Ratings
HC Wainwright & Co. Buy May 13, 24
Baird Outperform May 13, 24
Jefferies Hold Apr 12, 24
HC Wainwright & Co. Buy Mar 25, 24
HC Wainwright & Co. Buy Jan 22, 24
Baird Outperform Jan 19, 24
Baird Outperform Jan 17, 24